As of April 16, 2025, Verastem Oncology (VSTM) has a market cap of $0.25 billion USD. According to our data, Verastem Oncology is ranked No.6747 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.25 B |
7.64%
|
Dec 31, 2024 | $0.23 B |
-36.49%
|
Dec 29, 2023 | $0.36 B |
69.58%
|
Dec 30, 2022 | $0.21 B |
-80.49%
|
Dec 31, 2021 | $1.09 B |
-3.76%
|
Dec 31, 2020 | $1.14 B |
58.96%
|
Dec 31, 2019 | $0.72 B |
-60.12%
|
Dec 31, 2018 | $1.79 B |
9.45%
|
Dec 29, 2017 | $1.64 B |
174.11%
|
Dec 30, 2016 | $0.60 B |
-39.78%
|
Dec 31, 2015 | $0.99 B |
-79.65%
|
Dec 31, 2014 | $4.88 B |
-19.82%
|
Dec 31, 2013 | $6.09 B |
29.69%
|
Dec 31, 2012 | $4.69 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$10.23 B |
0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.76 B |
-0.000 M
|
![]() Canada
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Karyopharm Therapeutics
KPTI
|
$35.85 M |
-0.000 M
|
![]() USA
|
![]() Syndax Pharmaceuticals
SNDX
|
$0.97 B |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
0.000 M
|
![]() USA
|
![]() BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
![]() China
|
Market Cap | = | VSTM Stock Price | * | VSTM Shares Outstanding |
= | $4.81 | * | 51.49 M | |
= | $0.25 B |